Consortia for Standardized Development

UBC outcomes research experts have developed an innovative consortium-focused approach to the development of outcomes instrument development. We bring together multi-sponsored consortia that combine scientific resources from several companies with teams of independent experts and organizations to develop unified research instruments that benefit the entire health care community, including health care providers, research experts, regulatory authorities, and manufacturers.

Two therapeutic areas are currently being addressed by this approach:

  • Chronic obstructive pulmonary disease (COPD)
  • Mild cognitive impairment (MCI)/Alzheimer’s disease (AD).

Both initiatives are multi-sponsor projects that have brought together experts in instrument development and validation, international clinicians and researchers, as well as expert representatives from regulatory agencies, to develop a single, validated patient-reported outcome (PRO) measure in each area. A key element of these projects has been the interest and enthusiasm of the industry sponsors, regulatory agencies, and the content experts committed to improving PRO evaluation through this innovative, cooperative program.

Current consortia projects: